Survival improvement in coccidioidal meningitis by high-dose intrathecal amphotericin B
- 1 October 1986
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 146 (10) , 2013-2018
- https://doi.org/10.1001/archinte.146.10.2013
Abstract
Research from JAMA Internal Medicine — Survival Improvement in Coccidioidal Meningitis by High-Dose Intrathecal Amphotericin BThis publication has 10 references indexed in Scilit:
- High-Dose Ketoconazole for Treatment of Fungal Infections of the Central Nervous SystemAnnals of Internal Medicine, 1983
- Treatment of Systemic Mycoses with Ketoconazole: Emphasis on Toxicity and Clinical Response in 52 PatientsAnnals of Internal Medicine, 1983
- Ketoconazole for Treatment of Disseminated CoccidioidomycosisAnnals of Internal Medicine, 1982
- Ketoconazole treatment of nonprimary coccidioidomycosisThe American Journal of Medicine, 1982
- Coccidioidal Meningitis and Intrathecal CorticosteroidsAnnals of Internal Medicine, 1981
- Amphotericin B-induced myelopathyArchives of internal medicine (1960), 1980
- COCCIDIOIDOMYCOSIS .1.Published by Elsevier ,1978
- COCCIDIOIDOMYCOSIS .2.Published by Elsevier ,1978
- Ventricular Fluid and the Management of Coccidioidal MeningitisAnnals of Internal Medicine, 1972
- COCCIDIOIDAL MENINGITIS - USE OF AMPHOTERICIN B IN TREATMENT1961